Yahoo Web Search

  1. The long-running patent feud over CRISPR-Cas9 gene editing appears to be over, just as U.S. biotech companies gear up for the first human tests of the landmark technology. This week, a federal ...

  2. For decades, the medical community has ignored mountains of evidence to wage a cruel and futile war on fat people, poisoning public perception and ruining millions of lives. It's time for a new approach to this health epidemic.

  3. The following are some of today's top gainers in the pharma/biotech sector..

  4. The potential drugs are meant to bind to "cannabinoid receptors," which are located on almost every organ and can help regulate immune response, the nervous system and more.

  5. ACOR announced that the FDA has extended time to review its new drug application (NDA), which seeks an approval for its Parkinson's disease candidate Inbrija. The FDA postponed ...

  6. In a new study reported in Genes and Development, a research team centered at University of Tsukuba has developed a novel approach for revealing how the brain forms via the creation of ...

  7. Parkinson's disease psychosis. Acadia further stated that ''[t]he FDA approval of NUPLAZID was based on data from the pivotal Phase III Study -020 and other supportive studies, ...

  8. Hemp CBD v. Medical Marijuana

    Daytona Beach News-Journal4 days ago

    Hemp cannabidiol oil, commonly referred to as CBD. What tends to trip many consumers up is how hemp CBD oil is different than medical marijuana. The main difference between the two is hemp CBD ...

  9. An experimental autism drug will be more extensively tested next year by researchers at UC San Diego, where a small clinical trial showed early signs of effectiveness in 2017. The trial ...

  10. Researchers at University of Utah Health found that ADHD patients had an increased risk of developing Parkinsons and Parkinson-like diseases than individuals with no ADHD ...

  1. 1234569 results